These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8013376)

  • 1. Regulation of estradiol 17 beta-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells.
    Reed MJ; Rea D; Duncan LJ; Parker MG
    Endocrinology; 1994 Jul; 135(1):4-9. PubMed ID: 8013376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acids increase 17 beta-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, and cyclic adenosine 3',5'-monophosphate only in JEG-3 cells.
    Piao YS; Peltoketo H; Jouppila A; Vihko R
    Endocrinology; 1997 Mar; 138(3):898-904. PubMed ID: 9048588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of aromatase cytochrome P-450 and 17 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels in choriocarcinoma cells.
    Ritvos O; Voutilainen R
    Endocrinology; 1992 Jan; 130(1):61-7. PubMed ID: 1309352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Couture P; Thériault C; Simard J; Labrie F
    Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of 3 beta-hydroxysteroid dehydrogenase and 17 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3',5'-monophosphate and phorbol myristate acetate in human choriocarcinoma cells.
    Tremblay Y; Beaudoin C
    Mol Endocrinol; 1993 Mar; 7(3):355-64. PubMed ID: 8387158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of 3-ketosteroid reductase messenger ribonucleic acid levels and 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase activity in rat liver by sex steroids and pituitary hormones.
    Couet J; Simard J; Martel C; Trudel C; Labrie Y; Labrie F
    Endocrinology; 1992 Dec; 131(6):3034-44. PubMed ID: 1446638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential estrogenic 17beta-hydroxysteroid dehydrogenase activity and type 12 17beta-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes.
    Bellemare V; Laberge P; Noël S; Tchernof A; Luu-The V
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):129-34. PubMed ID: 19429442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8.
    Speirs V; Green AR; Atkin SL
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):267-74. PubMed ID: 9879985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue.
    Pollow K; Boquoi E; Baumann J; Schmidt-Gollwitzer M; Pollow B
    Mol Cell Endocrinol; 1977 Feb; 6(4-5):333-48. PubMed ID: 14041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of type I 17beta-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma.
    Kasai T; Shozu M; Murakami K; Segawa T; Shinohara K; Nomura K; Inoue M
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5661-8. PubMed ID: 15531526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal regulation of oxidative and reductive activities of 11 beta-hydroxysteroid dehydrogenase in rat Leydig cells.
    Gao HB; Ge RS; Lakshmi V; Marandici A; Hardy MP
    Endocrinology; 1997 Jan; 138(1):156-61. PubMed ID: 8977399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
    Gingras S; Moriggl R; Groner B; Simard J
    Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent.
    Jing Y; Zhang J; Waxman S; Mira-y-Lopez R
    Differentiation; 1996 May; 60(2):109-17. PubMed ID: 8641545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
    Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell lines.
    Day JM; Tutill HJ; Newman SP; Purohit A; Lawrence HR; Vicker N; Potter BV; Reed MJ
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):246-9. PubMed ID: 16490301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
    Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
    Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.